美国 · SEC FORM 4
STRYKER CORP
SYK · NYSE · CIK 0000310764 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
58 同一窗口内观察到的 Form 4 交易行
36 sales · 22 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 10 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-11-22 · BRAINERD MARY K.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 5,737,895
- 上期报告
- 7,671,881
- 日均成交量
- 2,842,108
- 回补天数
- 2.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2022-11-22 | BRAINERD MARY K | 买入 (P) | Common Stock | 18 | USD 225.20 | USD 4,054 | SEC 申报 ↗ |
| 2020-07-31 | Doliveux Roch | 买入 (P) | Common Stock | 53 | USD 191.94 | USD 10,173 | SEC 申报 ↗ |
| 2020-06-12 | BRAINERD MARY K | 买入 (P) | Common Stock | 3 | USD 185.65 | USD 557 | SEC 申报 ↗ |
| 2020-05-12 | BRAINERD MARY K | 买入 (P) | Common Stock | 36 | USD 193.21 | USD 6,956 | SEC 申报 ↗ |
| 2020-04-30 | Doliveux Roch | 买入 (P) | Common Stock | 51 | USD 190.09 | USD 9,695 | SEC 申报 ↗ |
| 2020-01-31 | Doliveux Roch | 买入 (P) | Common Stock | 45 | USD 216.67 | USD 9,750 | SEC 申报 ↗ |
Form 4 申报证据
137 transaction lines in the latest 365-day window; 718 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Wells Preston Wendell | J (J) | Common Stock | 109 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-22 | Wells Preston Wendell | J (J) | Common Stock | 962 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-21 | Crotty Dylan Bram | 卖出 (S) | Common Stock | 441 | USD 328.61 | USD 144,917 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Wells Preston Wendell | J (J) | Common Stock | 109 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-22 | Wells Preston Wendell | J (J) | Common Stock | 962 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-21 | Crotty Dylan Bram | 卖出 (S) | Common Stock | 441 | USD 328.61 | USD 144,917 | SEC 申报 ↗ |
| 2026-08-19 | STRYKER RONDA E | 卖出 (S) | Common Stock | 50,000 | USD 340.11 | USD 17,005,252 | SEC 申报 ↗ |
| 2026-08-18 | STRYKER RONDA E | 卖出 (S) | Common Stock | 300,000 | USD 335.90 | USD 100,770,548 | SEC 申报 ↗ |
| 2026-08-18 | King Debra | 卖出 (S) | Common Stock | 826 | USD 336.30 | USD 277,784 | SEC 申报 ↗ |
| 2026-08-01 | Montagnino Kimberly Ann | 代扣税 (F) | Common Stock | 155 | USD 325.70 | USD 50,484 | SEC 申报 ↗ |
| 2026-08-01 | King Debra | 代扣税 (F) | Common Stock | 533 | USD 325.70 | USD 173,598 | SEC 申报 ↗ |
| 2026-08-01 | Fletcher Robert S | 代扣税 (F) | Common Stock | 94 | USD 325.70 | USD 30,616 | SEC 申报 ↗ |
| 2026-08-01 | Fink M Kathryn | 代扣税 (F) | Common Stock | 111 | USD 325.70 | USD 36,153 | SEC 申报 ↗ |
| 2026-07-17 | Wells Preston Wendell | J (J) | Common Stock | 1,777 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | Stiles Spencer S | 赠与 (G) | Common Stock | 1,607 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-28 | Fletcher Robert S | 卖出 (S) | Common Stock | 4,544 | USD 306.87 | USD 1,394,403 | SEC 申报 ↗ |
| 2026-05-26 | STRYKER RONDA E | 卖出 (S) | Common Stock | 310,000 | USD 312.23 | USD 96,792,758 | SEC 申报 ↗ |
| 2026-05-11 | Fink M Kathryn | 卖出 (S) | Common Stock | 8,720 | USD 283.69 | USD 2,473,772 | SEC 申报 ↗ |
| 2026-05-08 | Fink M Kathryn | 期权行权/转换 (M) | Common Stock | 21,582 | USD 167.98 | USD 3,625,388 | SEC 申报 ↗ |
| 2026-05-08 | Fink M Kathryn | 代扣税 (F) | Common Stock | 16,362 | USD 294.23 | USD 4,814,191 | SEC 申报 ↗ |
| 2026-05-06 | Suri Rajeev | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | Skeete Tatum Lisa M | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | Silvernail Andrew K | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | STRYKER RONDA E | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | Ruggeri Rachel | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | Montagnino Kimberly Ann | 奖励/授予 (A) | Common Stock | 677 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | McCoy Sherilyn S | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | Maceda Emmanuel Perez | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | King Debra | 奖励/授予 (A) | Common Stock | 1,016 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | Caforio Giovanni | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | BRAINERD MARY K | 奖励/授予 (A) | Common Stock | 762 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-21 | Wells Preston Wendell | 代扣税 (F) | Common Stock | 204 | USD 335.67 | USD 68,477 | SEC 申报 ↗ |
| 2026-03-21 | Stiles Spencer S | 期权行权/转换 (M) | Common Stock | 430 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SYK |
| CIK | 0000310764 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 718 transaction lines from 2020-01-29 to 2026-09-24 6 P purchase lines · 238 S sale lines · 474 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.